Director Dealings - LTIP
Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
(“PHP” or the “Company”)
28 October 2026
Director/PDMR Shareholding
Director Dealings - LTIP
Primary Health Properties PLC, announces that the Remuneration Committee has approved the
following awards of nil-cost options under the Company’s 2021 Long-term Incentive Plan (“LTIP”) to
Directors as follows:
Director Number of shares under option
Mark Davies 1,400,871
Richard Howell 857,843
The number of nil-cost options were calculated by reference to a price of £0.9180, being the average
of the closing middle market quotations for the Company’s ordinary shares on 22, 23 and 26 October
2026.
The nil-cost options will vest subject to the attainment of performance conditions measured over three
years to 31 December 2028. The remuneration committee has the discretion to adjust the awards
downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the
Company’s 2025 Report and Accounts.
Details of the transactions referenced above are included below in accordance with the under Article
19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Mark Davies
2 Reason for notification
(a) Position/Status Chief Executive Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company’s ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 1,400,871
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 27 October 2026
(f) Place of transaction N/A
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform,
auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date: and (iv) each place where transactions
have been conducted
(a) Description of the financial instrument, type Ordinary shares of 12.5p
of instrument and identification code ISIN: GB00BYRJ5J14
(b) Nature of transaction Award of nil-cost options over the
Company’s ordinary shares
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 857,843
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 27 October 2026
(f) Place of transaction N/A
For further information
Mark Davies CEO Richard Howell CFO
Primary Health Properties PLC Primary Health Properties PLC
David Purcell Investor Relations
Primary Health Properties PLC
T: +44 (0) 7921 190 136
E: david.purcell@phpgroup.co.uk
Sodali & Co Financial PR
Elly Williamson/Madeleine Gordon-Foxwell
T: +44 (0) 207 250 1446
E: PHP@client.sodali.com
The Company has a primary listing on the London Stock Exchange and a secondary listing on the
JSE Limited.
United Kingdom
Sponsor: PSG
Date: 28/10/2026 05:01:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.